ENOV Stock Analysis: Buy, Sell, or Hold?
ENOV - Enovis Corporation
$25.75
0.53 (2.10%)
▲
5d:
+14.44%
30d:
+7.47%
90d:
+7.29%
HOLD
MODERATE Confidence
Analysis Updated: Jul 10, 2026 12:00 AM ET
Earnings: Aug 06, 2026
23d
Get Alerted When ENOV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: ENOV is 8.0% above its trading range ($23.84). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: ENOV is 8.0% above its trading range ($23.84). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$38.72
Based on 7.9% avg growth
INTRINSIC VALUE TODAY
$24.04
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 6.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ENOV is currently trading at $25.75, which is considered extended relative to its 30-day fair value range of $20.88 to $23.84. The stock's valuation (Forward PE: 6.3) is in line with its historical norms (6.5). Remarkably, the market is currently pricing in an annual earnings decline of 0.8% over the next few years. This pessimistic expectation contrasts with the company's recent 153.1% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, ENOV is showing sideways momentum. The price is approaching resistance at $26.50. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ENOV has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $40.73 (+58.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ENOV is showing sideways momentum. The price is approaching resistance at $26.50. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ENOV has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $40.73 (+58.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$20.88 -
$23.84
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BEARISH: Price extended above range (+8.0% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 58.2% below Wall St target ($40.73)
Trading Range Analysis
30-Day Trading Range
$20.88 -
$23.84
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$19.14
Resistance Level
$26.50
Current Trend
Sideways
Technical data as of
Jul 10, 2026
Fundamental Context
Forward P/E (Next Year Est.)
6.31
Wall Street Target
$40.73
(+58.2%)
Revenue Growth (YoY)
5.4%
Earnings Growth (YoY)
153.1%
Profit Margin
-49.9%
Valuation Discount vs History
-0.8% cheaper
PE vs Historical
6.3 vs 6.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.8%
(market-implied from PE analysis)
1-Year Target
$25.54
(-1%)
2-Year Target
$25.34
(-2%)
3-Year Target
$25.14
(-2%)
3-Yr Target (if PE normalizes)
(PE: 6→7)
$25.89
(+1%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 11.8%)
$124.30
(+383%)
Base:
(SPY PE: 6.3, Growth: 11.8%)
$36.02
(+40%)
Bear:
(PE: 5.4, Growth: 11.8%)
$30.62
(+19%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 6.3 to 6.5
Stabilization Target:
$26.52
(+3.0%)
PE Expansion Potential:
+3.0%
Share & Embed Analysis
Last updated: July 13, 2026 4:03 AM ET
Data refreshes hourly during market hours. Next update: 5:03 AM
Data refreshes hourly during market hours. Next update: 5:03 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ENOV showing a specific setup today?
Insider Activity (6 Months)
6
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Oliver Engert
BUY
1000 shares
2026-03-13
Oliver Engert
BUY
1000 shares
2026-03-09
Oliver Engert
BUY
750 shares
2026-03-06
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$74 | 65 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$386 | 63 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$116 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$97 | 66 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$239 | 58 HOLD |
